Pharmaceutical Company Lek Increases Revenues by 35 Percent in 2001
Ljubljana, 28 January - The pharmaceutical group Lek increased its total sales revenues by 34.6 percent in 2001, generating 80 billion tolars (360 million euros) from sales, the CEO of Lek Metod Dragonja told Monday's press conference in Ljubljana at which he presented preliminary company results for last year.
The rest of this news item is available to subscribers.
The news item consists of 2.173 characters (without spaces) or 427 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.